DHEC Supports CDC Recommendation for Certain Ages to Wait Eight Weeks Between Doses of Two-Shot COVID-19 Vaccines
FOR IMMEDIATE RELEASE February 23, 2022
COLUMBIA, S.C. — The Centers for Disease Control and Prevention (CDC) on Tuesday updated its Interim Clinical Considerations for Use of COVID-19 Vaccines with a recommendation for certain ages when receiving an initial COVID-19 vaccination series.
According to the federal agency, individuals ages 12-64 who are not immunocompromised may benefit from waiting eight weeks between the first and second doses of the Pfizer or Moderna vaccine instead of the 3-4 weeks approved by the U.S. Food and Drug Administration (FDA).
DHEC supports this recommendation and encourages individuals seeking a COVID-19 vaccination to talk to their healthcare providers about this timeframe and what works best for them.
According to the CDC, benefits of waiting the additional 4-5 weeks include: giving the body an opportunity to build a stronger immune response to COVID-19 and a lessened risk of myocarditis and pericarditis, which already are extremely rare side effects of the vaccine.
Those who have already completed their vaccination series within the normal timeframe remain well-protected against a severe case of COVID-19, especially if they have received a booster once eligible.
Vaccination continues to be the most effective way to control COVID-19. Everyone can help keep COVID-19 cases low by getting vaccinated and boosted, wearing masks indoors around others, and limiting participating in large in-person gatherings with those you don’t live with.
###
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
